Bioscience

OmniGuide reports positive results in Beampath pre-clinical trial

July 6, 2009

By Flinn Foundation

[Source: MassDevice.com] –  OmniGuide said a pre-clinical trial of its BeamPath flexible CO2 laser fiber scalpel showed the device made precise cuts in pigs’ brain tissue with little damage to neighboring tissues.

The study, conducted by researchers at the Barrow Neurological Institute in Phoenix (which also funded the study using materials supplied by OmniGuide), compared the BeamPath scalpel with a standard procedure called bipolar electrocautery, according to Yair Schindel, OmniGuide’s VP of clinical affairs and business development.

For more information: OmniGuide reports positive results in Beampath pre-clinical trial